Loading chat...
MT HB399
Bill
Status
Passed
4/16/2025
Primary Sponsor
Jonathan Karlen
Click for details
AI Summary
- Prohibits prior authorization for formulary oral and inhaled nonbiologic generic prescription drugs that are not controlled substances or Medicare Part D specialty tier drugs
- Prohibits prior authorization for formulary inhaled prescription drugs (generic or brand name) used to treat asthma, chronic obstructive pulmonary disease, or chronic lung disease
- Prohibits prior authorization for formulary generic or brand name insulin for patients diagnosed with diabetes
- Requires adverse determinations during prior authorization to be made by a physician whose specialty focuses on the condition being treated
- Requires insurers making adverse determinations to provide written notice including a list of reasonable therapeutic alternatives covered by the formulary
Legislative Description
Revise prior authorization laws
Health
Last Action
Chapter Number Assigned
4/17/2025
Committee Referrals
Business, Labor and Economic Affairs3/5/2025
Business & Labor2/10/2025
Human Services2/6/2025
Full Bill Text
No bill text available